Eli Lilly Trial Finds Alzheimer’s Drug Can Slow Progress of Disease
Donanemab is not a cure and comes with significant side effects, but patients had longer periods of independent living while on the drug.
Posted inbiosimilars California CalRx Diabetes Discount Selling Drugs (Pharmaceuticals) Eli Lilly and Company Generic Brands and Products Government Contracts and Procurement Inflation Reduction Act of 2022 Insulin Law and Legislation Novo Nordisk A/S Prices (Fares, Fees and Rates) Sanofi SA
California’s Plan for Cheaper Insulin Collides With Big Pharma’s Price Cuts
The state awarded a $50 million contract to produce less costly treatments, but moves by major suppliers might undercut the initiative before any new product emerges.
Posted inDiabetes Drugs (Pharmaceuticals) Eli Lilly and Company Health Insurance and Managed Care Insulin Novo Nordisk A/S Prices (Fares, Fees and Rates) Sanofi SA
Sanofi Plans to Cut the Price of Insulin
The company is the third of the three major insulin manufacturers that dominate the U.S. market to announce such a move this month.
Posted inDrugs (Pharmaceuticals) Eli Lilly and Company Insulin Novo Nordisk A/S Prices (Fares, Fees and Rates)
Novo Nordisk Says It Will Slash the Price of Insulin
The company’s decision follows a similar move by its rival, Eli Lilly, this month.